Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Clinical trial NCT03112174 · COMPLETED
Trial details
- NCT number
- NCT03112174
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-19
- Primary completion
- 2024-06-26
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.